uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Febseltiq
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/005361
ATC code
L01E
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of cholangiocarcinoma.
MeSH:
Cholangiocarcinoma
Group:
Antineoplastic agents
Active substances
Infigratinib monophosphate
Marketing Authorisation Holder
Helsinn Birex Pharmaceuticals Ltd
MAH
Febseltiq | uMedical